India will on Tuesday make its first shipment of a locally made COVID-19 shot to the WHO-backed equitable vaccine distribution network #COVAX
South Africa has asked the Serum Institute of India to take back the one million COVID-19 vaccine doses the company had sent in early February, The Economic Times reported on Tuesday, a week after the country said it will put on hold use of AstraZenecas shot in its vaccination program.
South Africas health minister has said the government may sell doses of AstraZenecas vaccine, after the country paused its rollout following a small clinical trial that showed it offered minimal protection against mild to moderate illness from the 501Y.V2 coronavirus variant dominant in the country.
AstraZeneca has said its vaccine appeared to offer only limited protection against mild disease caused by the South African variant, based on data from a study by South Africas University of the Witwatersrand and Oxford University.
The African country, which is yet to launch its COVID-19 vaccination program, has decided to start vaccinating health workers with Johnson & Johnsons vaccine in the form of an "implementation study" with researchers.